Blue chips, tech, health drag on ASX – The Australian Financial Review

Clinuvel Pharmaceuticals shares fell 8.3 per cent to $32.55 ahead of its Wednesday annual general meeting when it could face a second strike and a possible spill. Proxy firm Ownership Matters told clients to vote against the remuneration report at the AGM.
…

Click here to view the original article.